...which they measured those pharmacies was totally inappropriate and incorrect."While the inspection reports for the drug makers almost never see the light of day, the pharmacy reports have, Miller said."The interesting thing is the agency...
...making big moves:? Pfizer dropped 4 percent after the drug maker's results fell short of what analysts had expected...drug, crimped revenue. The world's second-largest drug maker also cut its profit forecast for the rest of the year...
...at scores of anti-aging medical practices and clinics around the country. Those numbers could be tallied only by drug makers, who have declined to say how many patients they supply and for what conditions.First marketed in 1985 for children...
...500 billion." THE FACTS: The tax increases fall heavily on upper-income people, health insurance companies, drug makers and medical device manufacturers. People who fail to obtain health insurance as required by the law will face a tax...
...that deciding now that genes can't be patented would throw into chaos current research and profits structures for drug-makers and medical research companies, who have gotten more than 40,000 DNA-related patents in almost 30 years, according...
ATLANTA --- A Danish drug maker moved Friday to curb the use of one of its sedatives in U.S. executions by requiring distributors to sign an agreement that...
LONDON - Growing sales in Japan and emerging markets have propelled drug maker GlaxoSmithKline to a 7 percent rise in profit in the third quarter, in line with market forecasts.The company reported Wednesday...
...ended business year.GlaxoSmithKlinein takeover bidLONDON - GlaxoSmith Kline PLC has made an offer to take over U.S. drug maker Human Genome Sciences Inc. which values the company at nearly $2.6 billion.GlaxoSmithKline, which has profit-sharing...
...that current stockpiles would suffice. A spokeswoman for London-based GlaxoSmithKline, the world's fourth largest drug maker by sales, said the company has enough inventory to meet demand until European flights resume.For now, the most obvious...
...counts Teva Pharmaceutical among her fund's top 10 holdings. Israel-based Teva is the world's biggest generic drug maker. Much of its business is overseas, including emerging markets where growth is expected to be faster than in the U...
The Augusta Chronicle ©2011. All Rights Reserved.